Equities

Saroja Pharma Industries India Ltd

SAROJA:NSI

Saroja Pharma Industries India Ltd

Actions
  • Price (INR)54.00
  • Today's Change0.00 / 0.00%
  • Shares traded4.80k
  • 1 Year change-15.63%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 08:07 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments3.223.642.65
Total Receivables, Net163112142
Total Inventory3.98394.67
Prepaid expenses------
Other current assets, total5.937.671.34
Total current assets176161151
Property, plant & equipment, net86403.42
Goodwill, net------
Intangibles, net00.010.03
Long term investments1.991.420.39
Note receivable - long term1.27100.37
Other long term assets--0.00--
Total assets266213155
LIABILITIES
Accounts payable565953
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases317444
Other current liabilities, total5.691.890.39
Total current liabilities9313498
Total long term debt262817
Total debt5710261
Deferred income tax0.090.130.03
Minority interest------
Other liabilities, total------
Total liabilities119163115
SHAREHOLDERS EQUITY
Common stock40292.26
Additional paid-in capital------
Retained earnings (accumulated deficit)1062238
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity1465140
Total liabilities & shareholders' equity266213155
Total common shares outstanding4.024.024.02
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.